The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review

The JAK/STAT Pathway and Its Selective Inhibition in the Treatment of Atopic Dermatitis: A Systematic Review

In recent years, the broadening understanding of the pathogenesis of atopic dermatitis (AD) has led to the development of novel therapeutic molecules, that target core inflammatory components of the disease. The Janus kinase (JAK)/signal transducer and activation of transcription (STAT) pathway cons...

Full description

Bibliographic Details
Main Authors: Aikaterini Tsiogka, Maria Kyriazopoulou, George Kontochristopoulos, Electra Nicolaidou, Alexander Stratigos, Dimitris Rigopoulos, Stamatios Gregoriou
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Journal of Clinical Medicine
Subjects:
atopic dermatitis
JAK/STAT pathway
treatment
JAK inhibitor
Th2 immune response
Janus kinase
Online Access:https://www.mdpi.com/2077-0383/11/15/4431

Internet

https://www.mdpi.com/2077-0383/11/15/4431

Similar Items